Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Dave L. Dixon, PharmD"'
Autor:
Pamela L. Alebna, MD, MPH, Chin Yip Han, MD, Mathew Ambrosio, MS, Gwyneth Kong, MD, John W. Cyrus, BA, Kayla Harley, BA, Le Kang, PhD, Aeron M. Small, MD, MTR, Parag Chevli, MBBS, MS, Harpreet Bhatia, MD, MAS, Nicholas Chew, MD, Fadi N. Salloum, PhD, Dave L. Dixon, PharmD, Antonio Abbate, MD, PhD, Pradeep Natarajan, MD, MMSc, Michael D. Shapiro, DO, MCR, Anurag Mehta, MD
Publikováno v:
JACC: Advances, Vol 3, Iss 12, Pp 101409- (2024)
Background: Lipoprotein(a) [Lp(a)] is an independent risk factor for atherosclerotic cardiovascular disease. The relationship between Lp(a) and major adverse cardiovascular events (MACE) in the context of high-sensitivity C-reactive protein (hs-CRP)
Externí odkaz:
https://doaj.org/article/d017bb550fd24b55a2dc766b2287a2c4
Autor:
Dhan Bahadur Shrestha, MD Resident Physician, Pravash Budhathoki, MD Resident Physician, Yub Raj Sedhai, MD, Ramkaji Baniya, MD, Casey A. Cable, MD, MSc, Markos G. Kashiouris, MD, MPH, Dave L. Dixon, PharmD, Jason M. Kidd, MD, Yuvraj Adhikari, MBBS, Anupama Marasini, MBBS, Shakar Bhandari, MBBS
Publikováno v:
Current Therapeutic Research, Vol 95, Iss , Pp 100635- (2021)
ABSTRACT: Background: Patiromer and sodium zirconium cyclosilicate (SZC) are newer options for hyperkalemia treatment. This systematic review and meta-analysis were conducted to assess the safety and side effect profile of patiromer and SZC compared
Externí odkaz:
https://doaj.org/article/17dcce8f1bb24a7ca3c57c9725ff9c97
Autor:
Salvatore Carbone, MS, Justin M. Canada, MS, RCEP, Leo F. Buckley, PharmD, Cory R. Trankle, MD, Hayley E. Billingsley, RD, Dave L. Dixon, PharmD, Adolfo G. Mauro, MS, Sofanit Dessie, MD, Dinesh Kadariya, MD, Eleonora Mezzaroma, PhD, Raffaella Buzzetti, MD, Ross Arena, PhD, Benjamin W. Van Tassell, PharmD, Stefano Toldo, PhD, Antonio Abbate, MD, PhD
Publikováno v:
JACC: Basic to Translational Science, Vol 2, Iss 5, Pp 513-525 (2017)
Heart failure with preserved ejection fraction (HFpEF) is associated with obesity and, indirectly, with unhealthy diet. The role of dietary components in HFpEF is, however, largely unknown. In this study, the authors showed that in obese HFpEF patien
Externí odkaz:
https://doaj.org/article/cda8dac8be7f46c2afda2865d2034634
Autor:
Dixon DL; Dave L. Dixon, PharmD, BCPS, CDE, CLS Assistant Professor, School of Pharmacy, Department of Pharmacotherapy & Outcomes Science, Virginia Commonwealth University, Richmond. Evan M. Sisson, PharmD, MHA, CDE Associate Professor, School of Pharmacy, Department of Pharmacotherapy & Outcomes Science, Virginia Commonwealth University. Michael Butler, PharmD Student, School of Pharmacy, Virginia Commonwealth University, Richmond. Ashley Higbea, PharmD Student, School of Pharmacy, Virginia Commonwealth University, Richmond. Brendan Muoio, PharmD Student, Virginia Commonwealth University School of Pharmacy, Richmond. Brandy Turner, PharmD Student, School of Pharmacy, Virginia Commonwealth University, Richmond., Sisson EM, Butler M, Higbea A, Muoio B, Turner B
Publikováno v:
The Journal of cardiovascular nursing [J Cardiovasc Nurs] 2014 Sep-Oct; Vol. 29 (5), pp. E7-E12.